Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients

BACKGROUND/AIMS: The utility of Baveno-VII criteria of clinically significant portal hypertension (CSPH) to predict decompensation in compensated advanced chronic liver disease (cACLD) patient needs validation. We aim to validate the performance of CSPH criteria to predict the risk of decompensation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Yu Jun, Zhaojin, Chen, Tosetti, Guilia, Degasperi, Elisabetta, Sharma, Sanchit, Agarwal, Samagra, Chuan, Liu, Huak, Chan Yiong, Jia, Li, Xiaolong, Qi, Saraya, Anoop, Primignani, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845679/
https://www.ncbi.nlm.nih.gov/pubmed/36064306
http://dx.doi.org/10.3350/cmh.2022.0181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845679/
https://www.ncbi.nlm.nih.gov/pubmed/36064306
http://dx.doi.org/10.3350/cmh.2022.0181

Ejemplares similares